The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

NAME OF REPORTING PERSONS

Thomas J. Schall, Ph.D.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐        (b)  ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

United States citizen

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

SOLE VOTING POWER

4,834,663 shares (1)

SHARED VOTING POWER

0 shares

SOLE DISPOSITIVE POWER

4,834,663 shares (1)

SHARED DISPOSITIVE POWER

0 shares

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,834,663 shares (1)

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

☐

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.1% (2)

TYPE OF REPORTING PERSON

IN

Includes 2,553,002 shares of common stock of ChemoCentryx, Inc. issuable upon the exercise of stock options granted to Dr. Schall that are exercisable within 60 days of December 31, 2018 and 96,667 shares of restricted stock units that vest within 60 days of December 31, 2018.

Based on 50,525,716 shares of common stock of ChemoCentryx, Inc. outstanding as of October 31, 2018, as reported in ChemoCentryx, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 filed on November 8, 2018.

Name of Issuer:

Address of Issuer’s Principal Executive Offices:

Name of Person Filing:

Address of Principal Business Office or, if None, Residence:

Citizenship:

Title of Class of Securities:

CUSIP Number:

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a:

☐ Broker or dealer registered under Section 15 of the Exchange Act.

☐ Bank as defined in Section 3(a)(6) of the Exchange Act.

☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act.

☐ Investment company registered under Section 8 of the Investment Company Act;

☐ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

☐ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

☐ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

☐ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);

☐ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

Ownership

Amount beneficially owned: 4,834,663 shares (1)

Percent of class: 9.1% (2)

Number of shares as to which such person has:

Sole power to vote or to direct the vote: 4,834,663 shares (1)

Shared power to vote or to direct the vote: 0 shares

Sole power to dispose or to direct the disposition of: 4,834,663 shares (1)

Shared power to dispose or to direct the disposition of: 0 shares

Ownership of Five Percent or Less of a Class:

Ownership of More than Five Percent on Behalf of Another Person:

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Identification and Classification of Members of the Group:

Notice of Dissolution of Group:

Certifications:

/s/ Thomas J. Schall, Ph.D.